MS-disease / Multiple Sclerosis

G6_MS

multiple sclerosis: A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 G35
Hospital discharge: ICD-9 340
Hospital discharge: ICD-8 34099
Cause of death: ICD-10 G35
Cause of death: ICD-9 340
Cause of death: ICD-8 34099
KELA reimbursements: KELA codes 109

2019

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

2009

diagram downward connector

Check minimum number of events None

2009

diagram downward connector

Include endpoints None

2009

diagram downward connector
G6_MS

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 G35-G37
Name in latin Sclerosis multiplex

Summary Statistics

Key figures

All Female Male
Number of individuals 2009 1511 498
Unadjusted prevalence (%) 0.56 0.76 0.32
Mean age at first event (years) 39.45 38.37 42.71

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.25 [1.37, 3.68] 1.3e-3 86
15 years 0.01 1.77 [1.12, 2.80] 1.4e-2 40
5 years 0.00 2.91 [1.76, 4.80] 3.2e-5 19
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: G6_MS – MS-disease / Multiple Sclerosis
GWS hits: 2

Survival analyses between endpoints

Plot

before MS-disease / Multiple Sclerosis
after MS-disease / Multiple Sclerosis

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after MS-disease / Multiple Sclerosis